Submitting Patient-Reported Outcome Data in Cancer Clinical Trials

Submitting Patient-Reported Outcome Data in Cancer Clinical Trials. This document provides technical specifications for submitting patient-reported outcome (PRO) data collected in cancer clinical trials to support a marketing application for a medical product in oncology, where a PRO is a type of clinical outcome assessment (COA) used to collect patient experience data.


Discover more from सुदर्शन

Subscribe to get the latest posts sent to your email.

error: Content is protected !!